Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats
- 31 August 2009
- journal article
- research article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 36 (6), 681-686
- https://doi.org/10.1016/j.nucmedbio.2009.03.009
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology, 2006
- PET with [ 18 F]fluorothymidine for imaging of primary breast cancer: a pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- [ 18 F]FLT PET for diagnosis and staging of thoracic tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- 3-[123I]Iodo-α-methyl-L-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology, 2002
- Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell linesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Thymidine concentrations in serum and urine of different animal species and manBiochemical Pharmacology, 1977